IMMX - IMMX ZY and SCOR among premarket gainers

Immix Biopharma (IMMX) +37%. Repare Therapeutics RPTX +28% on signing licensing deal with Repare Therapeutics for tumor candidate. Chewy CHWY +20% on Q1 results. UiPath PATH +12% on Q1 results. Blue Apron Holdings APRN +11% after launch of meal kits on Walmart. Pure Storage PSTG +11% on Q1 results. Zymergen (ZY) +10%. PDS Biotechnology PDSB +10% wins FDA Fast Track status for head and neck cancer therapy. MongoDB MDB +8% on Q1 results. Nextdoor Holdings KIND +8% on $100M stock buyback program. comScore (SCOR) +8%. Better Therapeutics (BTTX) +7%. Gamida Cell GMDA +6%. on completing rolling biologics license application submission to the FDA for Omidubicel.

For further details see:

IMMX, ZY and SCOR among premarket gainers